S100A9 and posterior cortical atrophy: Numerous prior investigations have demonstrated that the expression level of S100A9 in PCa tissues is significantly lower than that in benign prostatic hyperplasia tissues, thereby implying that the S100A9 protein serves as a suppressor of prostate cancer progression (96).